Review of Tumor Dormancy Therapy Using Traditional Oriental Herbal Medicine

키워드

참고문헌 (59)

2. 김진희, "2005년 암의 경제적 비용부담 추계", 예방의학회지, 42(3), pp.190~198 (2009), 대한예방의학회
3. Aguirre-Ghiso JA, "Models, mechanisms and clinical evidence for cancer dormancy", Nat Rev Cancer, 7(11), pp.834~846 (2007)
4. Brackstone M, "Tumour dormancy in breast cancer: an update", Breast Cancer Res, 9(3), pp.208~ (2007)
5. Udagawa T, "Tumor dormancy of primary and secondary cancers", APMIS, 116(7-8), pp.615~628 (2008)
6. Harach HR, "Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study", Cancer, 56(3), pp.531~538 (1985)
7. Black WC, "Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy", N Engl J Med, 328(17), pp.1237~1243 (1993)
8. Nielsen M, "Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies", Br J Cancer, 56(6), pp.814~819 (1987)
9. Cho CK, "Healthy herbal cancer treatment", pp.79~166 (2003), Taewoong Publishing
10. Cho CK, "Cancer dormancy therapy that makes prolong survival time by preventing recurrence and metastasis", pp.15~174 (2005), Dajung books Publishers
11. Cho CK, "New therapy strategy to prevent cancer recurrence and metastasis", pp.80~104 (2009), Garim Publishers
12. 강경아, "서울시 일 지역 주민의 인생회고 및 죽음준비 인식", 한국호스피스완화의료학회지, 14(2), pp.81~90 (2011), 한국호스피스완화의료학회
13. Kruger WH, "Disseminated breast cancer cells prior to and after high-dose therapy", J Hematother Stem Cell Res, 10(5), pp.681~689 (2001)
14. Braun S, "Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients", J Clin Oncol, 18(1), pp.80~86 (2000)
15. Hohaus S, "Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer", Br J Cancer, 79(9-10), pp.1500~1507 (1999)
16. Becker S, "Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients", Breast Cancer Res Treat, 106(2), pp.239~243 (2007)
17. Hoffman RM, "In vivo real-time imaging of nuclearcytoplasmic dynamics of dormancy, proliferation and death of cancer cells", APMIS, 116(7-8), pp.716~729 (2008)
18. MacKie RM, "Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery, In Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery", N Engl J Med, 348(6), pp.567~568 (2003)
19. Lage A, "Control of advanced cancer: the road to chronicity", Int J Environ Res Public Health, 8(3), pp.683~697 (2011)
20. Riethdorf S, "Review: biological relevance of disseminated tumor cells in cancer patients", Int J Cancer, 123(9), pp.1991~2006 (2008)
21. Barkan D, "Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton", Cancer Res, 68(15), pp.6241~6250 (2008)
22. Goodison S, "Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein", Clin Cancer Res, 9(10 Pt 1), pp.3808~3814 (2003)
23. Shachaf CM, "Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy", Cancer Res, 65(11), pp.4471~4474 (2005)
24. Gimbrone MA Jr, "Tumor dormancy in vivo by prevention of neovascularization", J Exp Med, 136(2), pp.261~276 (1972)
25. Holmgren L, "Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression", Nat Med, 1(2), pp.149~153 (1995)
26. O'Reilly MS, "Angiostatin induces and sustains dormancy of human primary tumors in mice", Nat Med, 2(6), pp.689~692 (1996)
27. Hart IR, "Perspective: tumour spread--the problems of latency", J Pathol, 187(1), pp.91~94 (1999)
28. Watnick RS, "Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis", Cancer Cell, 3(3), pp.219~231 (2003)
29. Mehes G, "Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow", Clin Cancer Res, 7(7), pp.1969~1975 (2001)
30. Mehes G, "Automatic detection and genetic profiling of disseminated neuroblastoma cells", Med Pediatr Oncol, 36(1), pp.205~209 (2001)
31. Witzig TE, "Detection of circulating cytokeratinpositive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy", Clin Cancer Res, 8(5), pp.1085~1091 (2002)
32. Rosenberg R, "Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood", Cytometry, 49(4), pp.150~158 (2002)
33. Pantel K, "Detection and clinical implications of early systemic tumor cell dissemination in breast cancer", Clin Cancer Res, 9(17), pp.6326~6334 (2003)
34. Ryschich E, "Transformation of the microvascular system during multistage tumorigenesis", Int J Cancer, 97(6), pp.719~725 (2002)
35. Koebel CM, "Adaptive immunity maintains occult cancer in an equilibrium state", Nature, 450(7171), pp.903~907 (2007)
36. Uhr JW, "Dormancy in a model of murine B cell lymphoma", Semin Cancer Biol, 11(4), pp.277~283 (2001)
37. Quesnel B, "Tumor dormancy and immunoescape", APMIS, 116(7-8), pp.685~694 (2008)
38. Wieder T, "T cell-mediated help against tumors", Cell Cycle, 7(19), pp.2974~2977 (2008)
39. Camargo MC, "Sex hormones, hormonal interventions, and gastric cancer risk: ameta-analysis", Cancer Epidemiol Biomarkers Prev, 21(1), pp.20~38 (2012)
40. Chambers AF, "Influence of diet on metastasis and tumor dormancy", Clin Exp Metastasis, 26(1), pp.61~66 (2009)
41. Holmgren L, "Antiangiogenis restricted tumor dormancy", Cancer Metastasis Rev, 15(2), pp.241~245 (1996)
42. Naumov GN, "Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases", Breast Cancer Res Treat, 82(3), pp.199~206 (2003)
43. Nagayama Y, "Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivo", Anticancer Res, 20(4), pp.2723~2728 (2000)
44. Aguirre Ghiso JA, "Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling", J Cell Biol, 147(1), pp.89~104 (1999)
45. Aguirre Ghiso JA, "Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo", Oncogene, 21(16), pp.2513~2524 (2002)
46. Aguirre-Ghiso JA, "ERK (MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38 (SAPK)", Cancer Res, 63(7), pp.1684~1695 (2003)
47. Kummar S, "A phase I study of the Chinese herbal medicine PHY906 as a modulator of irinotecanbased chemotherapy in patients with advanced colorectal cancer", Clin Colorectal Cancer, 10(2), pp.85~96 (2011)
48. Li Q, "SFECO2 extract from Typhoniumgiganteum Engl. tubers, induces apoptosis in human hepatoma SMMC-7721 cells involvement of a ROS-mediated mitochondrial pathway", Molecules, 16(10), pp.8228~8242 (2011)
49. Liu YH, "Effects of a Chinese herbal medicine, Guan-Jen- Huang (Aeginetiaindica Linn.), on renal cancer cell growth and metastasis", Evid Based Complement Alternat Med (2012)
50. Xu W, "Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt", beta-catenin pathway, 2011, pp.30(1), 103~
51. Jiang J, "Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA", Biochem Biophys Res Commun, 415(2), pp.325~329 (2011)
52. Telang NT, "Anti-proliferative effects of Chinese herb Cornusofficinalis in a cell culture model for estrogen receptor-positive clinical breast cancer", Mol Med Report, 5(1), pp.22~28 (2012)
53. Hsieh TC, "Suppression of proliferation and oxidative stress by extracts of Ganoderm alucidum in the ovarian cancer cell line OVCAR-3", Int J Mol Med, 28(6), pp.1065~1069 (2011)
54. Wang WB, "Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90", J Cell Physiol, 227(5), pp.2196~2206 (2012)
55. Tan W, "Berberine hydrochloride: anticancer activity and nanoparticulate delivery system", Int J Nanomedicine, 6, pp.1773~1777 (2011)
56. Zhong ZF, "Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo", J Ethnopharmacol, 141(2), pp.721~727 (2012)
57. Hong SH, "Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells", Oncol Rep, 27(1), pp.114~120 (2012)
58. Wu DC, "Effects of Pinus massoniana bark extract on the adhesion and migration capabilities of HeLa cells", Fitoterapia, 82(8), pp.1202~1205 (2011)
59. Lin J, "Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis", Mol Med Report, 4(6), pp.1283~1288 (2011)

관련 논문AI추천